U.S. Physical Therapy, Inc. (USPH) Stock Forecast
Data as of May 3, 2026Healthcare · Current price $72.03 (+1.14%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 9, 2026 | Jack Slevin | Jefferies | $102.00 | +41.6% |
Top Analysts Covering USPH
USPH vs Sector & Market
| Metric | USPH | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | +41.6% | +1150.2% | +14.9% |
| P/E Ratio | 50.73 | 6.82 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $207M | $211M | $216M | 5 |
| 2026-09-30 | $207M | $211M | $217M | 2 |
| 2026-12-31 | $212M | $216M | $222M | 2 |
| 2027-03-31 | $208M | $211M | $217M | 2 |
| 2027-06-30 | $220M | $223M | $230M | 2 |
| 2027-09-30 | $221M | $224M | $231M | 2 |
| 2027-12-31 | $226M | $230M | $237M | 2 |
| 2028-12-31 | $965M | $985M | $1.01B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.56 | $0.82 | $0.97 | 5 |
| 2026-09-30 | $0.72 | $0.74 | $0.77 | 1 |
| 2026-12-31 | $0.77 | $0.78 | $0.81 | 1 |
| 2027-03-31 | $0.62 | $0.63 | $0.65 | 1 |
| 2027-06-30 | $0.94 | $0.96 | $0.99 | 1 |
| 2027-09-30 | $0.84 | $0.86 | $0.89 | 1 |
| 2027-12-31 | $0.85 | $0.87 | $0.90 | 1 |
| 2028-12-31 | $3.78 | $3.88 | $4.02 | 1 |
Frequently Asked Questions
What is the analyst consensus for USPH?
The consensus among 3 analysts covering U.S. Physical Therapy, Inc. (USPH) is Buy with an average price target of $102.00.
What is the highest price target for USPH?
The highest price target for USPH is $102.00, set by Jack Slevin at Jefferies on 2026-03-09.
What is the lowest price target for USPH?
The lowest price target for USPH is $102.00, set by Jack Slevin at Jefferies on 2026-03-09.
How many analysts cover USPH?
3 analysts have issued ratings for U.S. Physical Therapy, Inc. in the past 12 months.
Is USPH a buy or sell right now?
Based on 3 analyst ratings, USPH has a consensus rating of Buy (2.00/5) with a +41.6% upside to the consensus target of $102.00.
What are the earnings estimates for USPH?
Analysts estimate USPH will report EPS of $0.82 for the period ending 2026-06-30, with revenue estimated at $211M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.